Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
Day: May 1, 2020
MiRNAs in teh Diagnosis of Cardiovascular Diseases Associated Wif Type 2 Diabetes Mellitus and Obesity
MiRNAs in teh Diagnosis of Cardiovascular Diseases Associated Wif Type 2 Diabetes Mellitus and Obesity
Interplay Between Epicardial Adipose Tissue, Metabolic and Cardiovascular Diseases
Interplay Between Epicardial Adipose Tissue, Metabolic and Cardiovascular Diseases
Effects of Curcumin on Cardiovascular Risk Factors in Obese and Overweight Adolescent Girls: A Randomized Clinical Trial
Effects of Curcumin on Cardiovascular Risk Factors in Obese and Overweight Adolescent Girls: A Randomized Clinical Trial
Obesity and Heart
Obesity and Heart
Obesity, Arterial Stiffness, and Cardiovascular Risk
Obesity, Arterial Stiffness, and Cardiovascular Risk
Pregnancy-driven Cardiovascular Maternal miR-29 Plasticity in Obesity
Pregnancy-driven Cardiovascular Maternal miR-29 Plasticity in Obesity
Update: Systemic Diseases and teh Cardiovascular System (me): Obesity and teh Heart
Update: Systemic Diseases and the Cardiovascular System (me): Obesity and the Heart
Effects of Adipocyte Expansion on Cardiovascular System and Ongoing Debate Over Obesity Paradox
Effects of Adipocyte Expansion on Cardiovascular System and Ongoing Debate Over Obesity Paradox
Cardiovascular Adaptation to Obesity and Hypertension
Cardiovascular Adaptation to Obesity and Hypertension